Efficacy and safety are the two considerations when characterising the effects of a new therapy. We sought to apply an innovative method of assessing the benefit–risk balance using data from a ...
Some improvements and clarifications of extended T-type procedures of multiple comparisons for unbalanced designs are given. In view of the general discussion, we obtain a procedure particularly ...